Cargando…
Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma
BACKGROUND: In patients with metastatic renal cell cancer, based on limited evidence, increased sunitinib exposure is associated with better outcome. The survival and toxicity data of patients receiving individualized dose escalated sunitinib therapy as compared to standard management were analyzed...
Autores principales: | Maráz, Anikó, Cserháti, Adrienn, Uhercsák, Gabriella, Szilágyi, Éva, Varga, Zoltán, Révész, János, Kószó, Renáta, Varga, Linda, Kahán, Zsuzsanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856318/ https://www.ncbi.nlm.nih.gov/pubmed/29544452 http://dx.doi.org/10.1186/s12885-018-4209-9 |
Ejemplares similares
-
Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series
por: Rusz, Orsolya, et al.
Publicado: (2018) -
Radiation dose to the nodal regions during prone versus supine breast irradiation
por: Csenki, Melinda, et al.
Publicado: (2014) -
Individually selected teletherapy technique for accelerated partial breast irradiation
por: Kószó, Renáta L., et al.
Publicado: (2021) -
Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data
por: Revesz, Janos, et al.
Publicado: (2023) -
Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility
por: Gaál, Szilvia, et al.
Publicado: (2021)